Actinogen Medical
-
Ticker
ACW
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 1-10 Employees
- Based in Sydney, Australia
Actinogen Medical is an ASX-listed biotechnology company developing novel therapies for neurological diseases associated with dysregulated brain cortisol.Actinogen Medical’s lead compound, Xanamem®, has been specifically designed to reduce production of intracellular cortisol - the stress hormone - through the inhibition of the 11β-HSD1 enzyme in the brain.
Actinogen Medical
Most Recent Annual Report
MOST RECENT
2021 Annual Report
Older/Archived Annual Reports